Lynn Million

NCCN Guidelines Insights: Bone Cancer, Version 2.2017

J. Sybil Biermann, Warren Chow, Damon R. Reed et al. · Journal of the National Comprehensive Cancer Network · 2017 · 299 citations · Full text

Medicine, Oncology, Surgery +15

Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials

Richard T. Hoppe, Cameron Harrison, Mahkam Tavallaee et al. · Journal of the American Academy of Dermatology · 2014 · 201 citations

Medicine, Clinical Sciences, Dermatology +5

Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group

Douglas S. Hawkins, Yueh-Yun Chi, James R. Anderson et al. · Journal of Clinical Oncology · 2018 · 175 citations

Medicine, Oncology, Radiation Oncology +17

A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study

Sheri L. Spunt, Lynn Million, Yueh-Yun Chi et al. · The Lancet Oncology · 2019 · 173 citations · Full text

Medicine, Oncology, Pediatrics +11

Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial

Aaron R. Weiss, Yen‐Lin Chen, Thomas J. Scharschmidt et al. · The Lancet Oncology · 2020 · 107 citations · Full text

Medicine, Oncology, Pediatrics +17